ChromaGenix
PrivateLast Round
Corporate Funding
Apr 22, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ChromaGenix is a biotechnology company that develops and manufactures synthetic affinity ligands and chromatography resins to improve the purification of complex biologics such as gene therapies, vaccines, and antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ChromaGenix Comparables
Compare ChromaGenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Repligen Corporation | 79% | |
| Danaher | 77% | |
| Merck | 77% |
ChromaGenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 22, 2025 |
ChromaGenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioProcess 360 Partners | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 188% MoM, reaching 1.3K.
- May 25, 2026
Grew 40% QoQ, from 10 to 14 employees.
ChromaGenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ChromaGenix's valuation, stock price, and market status.
Is ChromaGenix a public or private company?
ChromaGenix is a private company.
What is the current stock price of ChromaGenix?
ChromaGenix is a private company with no public stock price. No recent secondary market data is available.
How much is ChromaGenix worth (valuation)?
Valuation information for ChromaGenix is not publicly available.
Can I buy ChromaGenix stock?
ChromaGenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ChromaGenix's last funding round?
ChromaGenix's most recent funding round was Corporate Funding on April 22, 2025.
Who are the main investors in ChromaGenix?
Key investors in ChromaGenix include BioProcess 360 Partners.
Will ChromaGenix IPO soon?
No public IPO plans have been announced for ChromaGenix.
How can I track ChromaGenix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ChromaGenix's secondary market activity and sign up for updates.